Auteurs
Checkpoint
Ncbi
Racine
Checkpoint
Ncbi
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Checkpoint (Ncbi)

Index « Auteurs » - entrée « Kei Ikeda »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Kei Hayashida < Kei Ikeda < Kei Ishibashi  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 10.
Ident.Authors (with country if any)Title
000250 (2010) Masanobu Horikoshi [Japon] ; Takeshi Suzuki ; Makoto Sugihara ; Yuya Kondo ; Hiroto Tsuboi ; Takeaki Uehara ; Maasa Hama ; Kaoru Takase ; Shigeru Ohno ; Yoshiaki Ishigatsubo ; Yuri Yoshida ; Akira Sagawa ; Kei Ikeda ; Toshiyuki Ota ; Isao Matsumoto ; Satoshi Ito ; Takayuki SumidaComparison of low-field dedicated extremity magnetic resonance imaging with articular ultrasonography in patients with rheumatoid arthritis.
000935 (2013) Kei Ikeda [Japon] ; Daiki Nakagomi ; Yoshie Sanayama ; Mieko Yamagata ; Ayako Okubo ; Taro Iwamoto ; Hirotoshi Kawashima ; Kentaro Takahashi ; Hiroshi NakajimaCorrelation of radiographic progression with the cumulative activity of synovitis estimated by power Doppler ultrasound in rheumatoid arthritis: difference between patients treated with methotrexate and those treated with biological agents.
000A27 (2014) Taro Iwamoto ; Kei Ikeda ; Junichi Hosokawa ; Mieko Yamagata ; Shigeru Tanaka ; Ayako Norimoto ; Yoshie Sanayama ; Daiki Nakagomi ; Kentaro Takahashi ; Koichi Hirose ; Takao Sugiyama ; Makoto Sueishi ; Hiroshi NakajimaPrediction of relapse after discontinuation of biologic agents by ultrasonographic assessment in patients with rheumatoid arthritis in clinical remission: high predictive values of total gray-scale and power Doppler scores that represent residual synovial inflammation before discontinuation.
000A46 (2014) Yoshie Sanayama [Japon] ; Kei Ikeda ; Yukari Saito ; Shin-Ichiro Kagami ; Mieko Yamagata ; Shunsuke Furuta ; Daisuke Kashiwakuma ; Itsuo Iwamoto ; Takeshi Umibe ; Yasushi Nawata ; Ryutaro Matsumura ; Takao Sugiyama ; Makoto Sueishi ; Masaki Hiraguri ; Ken Nonaka ; Osamu Ohara ; Hiroshi NakajimaPrediction of therapeutic responses to tocilizumab in patients with rheumatoid arthritis: biomarkers identified by analysis of gene expression in peripheral blood mononuclear cells using genome-wide DNA microarray.
000A99 (2014) Yukari Saito [Japon] ; Shin-Ichiro Kagami ; Yoshie Sanayama ; Kei Ikeda ; Akira Suto ; Daisuke Kashiwakuma ; Shunsuke Furuta ; Itsuo Iwamoto ; Ken Nonaka ; Osamu Ohara ; Hiroshi NakajimaAT-rich-interactive domain-containing protein 5A functions as a negative regulator of retinoic acid receptor-related orphan nuclear receptor γt-induced Th17 cell differentiation.
000D45 (2015) Hiroaki Takatori [Japon] ; Hirotoshi Kawashima [Japon] ; Ayako Matsuki [Japon] ; Kazuyuki Meguro [Japon] ; Shigeru Tanaka [Japon] ; Taro Iwamoto [Japon] ; Yoshie Sanayama [Japon] ; Natsuko Nishikawa [Japon] ; Tomohiro Tamachi [Japon] ; Kei Ikeda [Japon] ; Akira Suto [Japon] ; Kotaro Suzuki [Japon] ; Shin-Ichiro Kagami [Japon] ; Koichi Hirose [Japon] ; Masato Kubo [Japon] ; Shohei Hori [Japon] ; Hiroshi Nakajima [Japon]Helios Enhances Treg Cell Function in Cooperation With FoxP3.
000E59 (2015) Kazuyuki Meguro [Japon] ; Kotaro Suzuki [Japon] ; Junichi Hosokawa [Japon] ; Yoshie Sanayama [Japon] ; Shigeru Tanaka [Japon] ; Shunsuke Furuta [Japon] ; Kei Ikeda [Japon] ; Hiroaki Takatori [Japon] ; Akira Suto [Japon] ; Akemi Sakamoto [Japon] ; Osamu Ohara [Japon] ; Hiroshi Nakajima [Japon]Role of Bcl-3 in the development of follicular helper T cells and in the pathogenesis of rheumatoid arthritis.
001C29 (2018) Yuko Kaneko [Japon] ; Hideto Kameda [Japon] ; Kei Ikeda [Japon] ; Tomonoti Ishii [Japon] ; Kosaku Murakami [Japon] ; Hyota Takamatsu [Japon] ; Yoshiya Tanaka [Japon] ; Takayuki Abe [Japon] ; Tsutomu Takeuchi [Japon]Tocilizumab in patients with adult-onset still's disease refractory to glucocorticoid treatment: a randomised, double-blind, placebo-controlled phase III trial.
001C76 (2019) Yuko Kaneko [Japon] ; Hideto Kameda [Japon] ; Kei Ikeda [Japon] ; Tomonori Ishii [Japon] ; Kosaku Murakami [Japon] ; Hyota Takamatsu [Japon] ; Yoshiya Tanaka [Japon] ; Takayuki Abe [Japon] ; Tsutomu Takeuchi [Japon]Response to: 'Tocilizumab in patients with adult-onset Still's disease refractory to glucocorticoid treatment' by Lee.
001D22 (2020) Yuko Kaneko [Japon] ; Hideto Kameda [Japon] ; Kei Ikeda [Japon] ; Tomonori Ishii [Japon] ; Kosaku Murakami [Japon] ; Hyota Takamatsu [Japon] ; Yoshiya Tanaka [Japon] ; Takayuki Abe [Japon] ; Tsutomu Takeuchi [Japon]Response to: 'Some concerns from Turkey' by Bilgin et al.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Ncbi/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i -k "Kei Ikeda" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i  \
                -Sk "Kei Ikeda" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Author.i
   |clé=    Kei Ikeda
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021